Faes Farma S.A Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €4.20 High: €4.25
on August 8, 2025

52 Week Range

Low: €3.27 High: €4.73
on March 17, 2025
on June 11, 2025

All-Time High: €19.40 on February 5, 2007

Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights

Key Statistics

Market Cap i €1.3B
EPS i 0.34
P/E Ratio (TTM) i 12.41
Forward P/E i 14.55
P/B Ratio i 1.80
PEG Ratio i 14.55
Div. Yield i 6.64%
ROE i 14.83%
Beta i 0.333
Debt to Equity i 11.48

Financial Highlights

Profitability

Gross Margin i 69.26%
Operating Margin i 18.19%
Profit Margin i 19.37%

Returns and Earnings

Return on Assets (TTM) i 6.92%
Return on Equity (TTM) i 14.83%
EBITDA i €155.4M
Net Income (TTM) i €105.3M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €1.75
Quarterly Revenue Growth (YoY) i 14.70%
Quarterly Earnings Growth (YoY) i -14.10%

Dividend Information

Last 12-Month Dividend i €0.30
Current Dividend Yield i 6.64%
3-Year Average Dividend Yield i 2.25%
3-Year Average Annual Dividend i €0.16
3-Year Total Dividends i €0.49
Ex-Dividend Date i July 3, 2025

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Faes Farma S.A FAE 1.31B Large-cap-3.21%-5.80%-0.24%15.30%20.23%19.89%7.11%21.97%
Laboratorios ROVI 2.72B Large-cap-2.03%-3.37%3.41%-4.32%-17.03%-32.16%1.36%86.38%
Almirall S.A ALM 2.20B Large-cap-3.21%-4.12%0.20%13.15%22.20%14.03%4.28%7.11%
Laboratorio Reig RJF 240.10M Mid-cap2.03%1.68%1.00%14.83%17.51%9.49%8.70%-20.84%
Labiana Health S.A LAB 28.16M Small-cap4.32%15.57%19.14%33.10%31.29%22.58%6,233.33%1,051.52%
Grifols, S.A GRF 7.93B Large-cap-2.06%22.50%57.28%54.08%35.84%46.52%-6.61%-47.55%

Ownership & Short Interest

Insider Ownership i 13.34%
Institutional Ownership i 19.57%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 220K
Average 90-Day Volume i 212K

Faes Farma S.A Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Faes Farma S.A would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Faes Farma S.A reached a high of €4.73 (on June 11, 2025) and a low of €3.27 (on March 17, 2025).
Curious about Faes Farma S.A's size and valuation? Its market capitalization stands at 1.31B. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.41, and the forward P/E (looking ahead) is 14.55.
Yes, Faes Farma S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 6.64%, and the company has paid an average of €0.16 per share annually over the past 3 years.

When looking at Faes Farma S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Laboratorios
ROVI
2.72BHealthcareDrug Manufacturers - Specialty & Generic-32.16%1.36%
Almirall S.A
ALM
2.20BHealthcareDrug Manufacturers - Specialty & Generic14.03%4.28%
Laboratorio Reig
RJF
240.10MHealthcareDrug Manufacturers - Specialty & Generic9.49%8.70%
Labiana Health S.A
LAB
28.16MHealthcareDrug Manufacturers - Specialty & Generic22.58%6,233.33%
Grifols, S.A
GRF
7.93BHealthcareDrug Manufacturers - General46.52%-6.61%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Faes Farma S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.83%, the Debt to Equity ratio from the most recent quarter is 11.48, and its Gross Profit Margin stands at 69.26%.
Looking at Faes Farma S.A's growth, its revenue over the trailing twelve months (TTM) was €544M. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.70%, and quarterly earnings saw a YoY growth of -14.10%.
Wondering who owns Faes Farma S.A stock? Company insiders (like executives and directors) hold about 13.34% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 19.57%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.